Status:
RECRUITING
Effect of the Mediterranean Diet in Patients Affected by CADASIL and Cerebral Amyloid Angiopathy.
Lead Sponsor:
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Conditions:
Cerebral Amyloid Angiopathy
CAA - Cerebral Amyloid Angiopathy
Eligibility:
All Genders
18+ years
Brief Summary
The study is divided into two phases: Phase 1 (observational) and Phase 2 (dietary intervention). The goal of Phase 1 is to assess the nutritional status and dietary habits of two cohorts of patients ...
Eligibility Criteria
Inclusion
- The study will include individuals of both sexes aged 18 years or older with a diagnosis of CADASIL (confirmed genetically by the presence of the NOTCH3 gene mutation) or possible/probable CAA (defined according to the Boston 2.0 criteria). All participants must provide informed consent for the use of demographic, clinical, and nutritional data for scientific purposes in an anonymous form
Exclusion
- na
Key Trial Info
Start Date :
October 10 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2026
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT06933212
Start Date
October 10 2024
End Date
July 31 2026
Last Update
April 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione IRCCS Istituto Neurologico Carlo Besta
Milan, Italy